-
Electronic (PDF)
-
Site License
-
Enterprisewide
BG Medicine, Inc. Product Pipeline Analysis
Global Markets Direct, January 2009, Pages: 26
BG Medicine, Inc. Product Pipeline Analysis
Summary
This report is an insightful source for data, analysis and strategic insights into a Scope’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.
Scope
- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.
Reasons to buy
- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
- Understand a companys strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
- Assess a companys future growth by determining its pipeline depth, for probable acquisition opportunities.
1 2
1.1 List Of Tables 5
1.2 List of Figures 6
2 Company Overview 7
2.1 Key Information 7
2.2 Industry Outlook - In Vitro Diagnostics 7
3 BG Medicine, Inc. Pipeline Products 8
3.1 BG Medicine, Inc. Product Pipeline Analysis 8
3.1.1 BG Medicine, Inc. Pipeline Products By Equipment Type 8
3.1.2 BG Medicine, Inc. Pipeline Products By Development Stage 9
3.1.3 BG Medicine, Inc. Pipeline Products By Therapy Area 10
3.1.4 BG Medicine, Inc. Pipeline Products By News Summary 10
3.2 Liver Toxicity Biomarker 11
3.2.1 Product Status 11
3.2.2 Product Description 11
3.2.3 Product Milestone 11
3.2.4 Product Institution Details 12
3.3 Plasma biomarkers assay 12
3.3.1 Product Status 12
3.3.2 Product Description 12
3.3.3 Product Milestone 12
3.3.4 Product Institution Details 13
3.4 Biomarker-based Molecular Diagnostic Test For Congestive Heart Failure 13
3.4.1 Product Status 13
3.4.2 Product Description 13
3.4.3 Product Milestone 14
3.5 Multiple sclerosis biomarkers assay 14
3.5.1 Product Status 14
3.5.2 Product Description 14
3.5.3 Product Milestone 15
3.6 Herceptin response test 15
3.6.1 Product Status 15
3.6.2 Product Description 15
3.7 Biomarker For Early Response To Tykerb 16
3.7.1 Product Status 16
3.7.2 Product Description 16
3.8 Biomarkers for Alzheimer’s disease 16
3.8.1 Product Status 16
3.8.2 Product Description 17
3.9 Markers for Tysabri efficacy 17
3.9.1 Product Status 17
3.9.2 Product Description 17
3.10 Biomarker of response to Avastin treatment 18
3.10.1 Product Status 18
3.10.2 Product Description 18
3.11 Molecular diagnostic test for Avandia treatment 18
3.11.1 Product Status 18
3.11.2 Product Description 19
3.12 Biomarker for detection of preeclampsia 19
3.12.1 Product Status 19
3.12.2 Product Description 19
3.13 Biomarkers for Enbrel and Remicade treatment 20
3.13.1 Product Status 20
3.13.2 Product Description 20
3.14 Diagnostic tests(acute atherothrombosis) 20
3.14.1 Product Status 20
3.14.2 Product Description 21
3.14.3 Product Milestone 21
4 Recent Developments 22
4.1 Product News 22
4.1.1 Feb 05, 2008: BG Medicine Acquires Exclusive Commercial Rights To Biomarker Of Vascular Plaque 22
4.1.2 Sep 18, 2007: Spinal Muscular Atrophy Foundation And BG Medicine Announce Collaboration 22
4.1.3 May 23, 2007: BG Medicine Acquires Exclusive Rights to Biomarkers of Congestive Heart Failure from ACS Biomarker 22
4.1.4 May 16, 2007: BG Medicine and Multiple Sclerosis Research Center of New York Announce Collaboration 23
5 Appendix 24
5.1 Methodology 24
5.1.1 Coverage 24
5.1.2 Secondary Research 25
5.1.3 Primary Research 25
5.1.4 Expert Panel Validation 26
5.2 Contact Us 26
5.3 About us26
5.4 Disclaimer 26
Executive Summary
1.2 List of Figures
Figure 1: BG Medicine, Inc. Pipeline Products By Development Stage 9
Figure 2: Global Markets Direct Methodology 24
The following companies are the major competitors of BG Medicine, Inc.:
Axon Lab AG
BioMed Diagnostics, Inc.
Virapur, LLC
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
